Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2015 2
2016 4
2017 3
2018 6
2019 9
2020 33
2021 27
2022 20
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
New Treatments for Myelofibrosis.
Tremblay D, Mesa R. Tremblay D, et al. Curr Treat Options Oncol. 2023 Feb;24(2):61-75. doi: 10.1007/s11864-023-01052-9. Epub 2023 Jan 14. Curr Treat Options Oncol. 2023. PMID: 36640223 Review.
Pharmacotherapy of Myelofibrosis.
Tremblay D, Marcellino B, Mascarenhas J. Tremblay D, et al. Drugs. 2017 Sep;77(14):1549-1563. doi: 10.1007/s40265-017-0797-y. Drugs. 2017. PMID: 28791654 Review.
Addressing symptom burden in myeloproliferative neoplasms.
Tremblay D, Mesa R. Tremblay D, et al. Best Pract Res Clin Haematol. 2022 Jun;35(2):101372. doi: 10.1016/j.beha.2022.101372. Epub 2022 Aug 12. Best Pract Res Clin Haematol. 2022. PMID: 36333066 Review.
Novel Therapies in Polycythemia Vera.
Tremblay D, Mascarenhas J. Tremblay D, et al. Curr Hematol Malig Rep. 2020 Apr;15(2):133-140. doi: 10.1007/s11899-020-00564-7. Curr Hematol Malig Rep. 2020. PMID: 32034662 Review.
Cytoreduction for ET and PV: who, what, when, and how?
Tremblay D. Tremblay D. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):660-666. doi: 10.1182/hematology.2023000451. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066871 Review.
Emerging Treatment Options for Myelofibrosis: Focus on Anemia.
Sastow D, Tremblay D. Sastow D, et al. Among authors: tremblay d. Ther Clin Risk Manag. 2023 Jun 28;19:535-547. doi: 10.2147/TCRM.S386802. eCollection 2023. Ther Clin Risk Manag. 2023. PMID: 37404252 Free PMC article. Review.
111 results